BSE filing, BSE: 544941. Summary written from the filing by ALFA Finder's alert engine.
FX Multitech Ltd: key numbers
- Share price
- ₹121.25
- Market cap
- ₹174.1 Cr
- Revenue (annual)
- ₹126.1 Cr
- Net profit (annual)
- ₹11.80 Cr
- P/E (TTM)
- 14.8×Sector 46.8×
- Promoter holding
- 72.84%
- FII holding
- 0.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from FX Multitech Ltd
All →FX Multitech H1 FY27 Results: Net Profit ₹4.4 Cr, Up 4.8% YoY
FX Multitech Ltd reported revenue from operations of ₹63.5 Cr (+19.4% YoY) and net profit of ₹4.4 Cr (+4.8% YoY) for H1 FY27.
- Key figure
- Net profit ₹4.4 Cr · +4.8% YoY
FX Multitech Board Meeting Date
FX Multitech has rescheduled its board meeting from 30 Oct to 04 Nov 2026. The postponement is due to auditors needing additional time to finalize half-year results.
FX Multitech Board Meeting Date
FX Multitech scheduled a board meeting for October 30, 2026, to approve H1 2026 unaudited financial results. Trading window stays closed until 48 hours post-results.
FX Multitech Other Announcement
FX Multitech Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, pursuant to SEBI Regulation 31(1)(b).
FX Multitech Capital Structure Change
Rajasthan Global Securities Private Limited acquired a 5.01% stake in FX Multitech Limited via an IPO allotment. The acquisition involving 7,20,000 shares marks a significant non-promoter investment.
Other other announcement announcements
All →Midwest Other Announcement
Midwest Ltd filed its quarterly BSE shareholding pattern for the quarter ended 30 September 2026. The filing is routine SEBI Reg 31 disclosure with no transaction.
Ansal Properties & Infrastructure Other Announcement
Ansal Properties informs exchanges of delay in Q2 FY27 results declaration due to pending Q1 finalization. No financial figures are reported in this filing.
Sai Life Science Other Announcement
Sai Life Sciences filed a Crisil monitoring agency report on IPO proceeds utilisation for the quarter ended 30 September 2026. It is a routine SEBI-mandated compliance certificate with no transaction or business event.
Ceat Other Announcement
Ceat Ltd notified BSE and NSE about loss of 11 share certificates held by Ambalal Mohanlal Kayastha. The RTA NSDL issued a public notice seeking information on the whereabouts of the original certificates.
Sigachi Industries Other Announcement
Sigachi Industries filed its quarterly IPO-proceeds monitoring agency report for the quarter ended 30.09.2026. Kotak Mahindra Bank confirmed no deviation from the stated objects of the offer.
Concord Biotech Other Announcement
Concord Biotech filed its quarterly shareholding pattern as of 5 November 2026. Promoters hold 39.54% of 20.92 crore shares.